Gabriele Neurauter

Learn More
BACKGROUND Tryptophan (TRP) degradation into kynurenine (KYN) by the enzyme, indoleamine-2,3-dioxygenase, during immune activation may contribute to development of depressive symptoms during interferon (IFN)-alpha therapy. METHODS Twenty-six patients with malignant melanoma were randomly assigned in double-blind fashion to receive either placebo or(More)
The deficit of these factors may cause excess hydroxyl-radical generation, leading to molecular and tissue damage. VE deficiency may affect nervous tissue in other ways, including overproduction of cytolytic phos-pholipids (22) and disturbance of brain monoamine metabolism (23). Other roles of VE, such as modulation of necrosis ␬B and AP1 transcription(More)
OBJECTIVE Higher blood levels of the essential amino acid phenylalanine (phe) have been documented in patients with HIV-1 infection. They may relate to a diminished conversion of phe to tyrosine (tyr) by the enzyme phenylalanine-hydroxylase (PAH). PAH is rate-limiting in the biosynthesis of dopamine, and impaired PAH activity is reflected by an increased(More)
Intrathecal production of neopterin, a pteridine produced by interferon (IFN)-gamma-stimulated monocyte-derived macrophages, is associated with neurological disorders and infections. We investigated whether IFN-alpha/beta, IFN-gamma, or human immunodeficiency virus (HIV) induce neopterin production by human astroglioma cells. IFN-alpha/beta and IFN-gamma,(More)
Immune system activation and inflammation accompanies immune dysfunction in trauma and sepsis patients. Immunodeficiency may develop in such patients as one consequence of an activated chronic pro-inflammatory response. According to recent data, degradation of L-tryptophan (TRP) via the kynurenine (KYN) pathway by the cytokine-inducible enzyme indoleamine(More)
  • 1